CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-05 | Eansor Norman David President-Protein Sciences | Sale | −3,700 | $382.60 | $1.4M | 4,318 |
| 2021-02-05 | Eansor Norman David President-Protein Sciences | Sale | −1,900 | $384.15 | $730K | 2,418 |
| 2021-02-05 | Eansor Norman David President-Protein Sciences | Sale | −1,100 | $385.59 | $424K | 1,318 |
| 2021-02-05 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −14,114 | 0 | ||
| 2021-02-05 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −18,819 | 0 | ||
| 2021-01-15 | Kummeth Charles R. Chief Executive Officer | Sale | −20,000 | $344.00 | $6.9M | 146,269 |
| 2021-01-11 | Hippel James Chief Financial Officer | Option exercise | +10,000 | $106.59 | $1.1M | 19,137 |
| 2021-01-11 | Hippel James Chief Financial Officer | Sale | −400 | $328.68 | $131K | 18,737 |
| 2021-01-11 | Hippel James Chief Financial Officer | Sale | −400 | $330.27 | $132K | 18,337 |
| 2021-01-11 | Hippel James Chief Financial Officer | Sale | −700 | $331.61 | $232K | 17,637 |
| 2021-01-11 | Hippel James Chief Financial Officer | Sale | −2,501 | $333.23 | $833K | 15,136 |
| 2021-01-11 | Hippel James Chief Financial Officer | Sale | −3,990 | $334.39 | $1.3M | 11,146 |
| 2021-01-11 | Hippel James Chief Financial Officer | Sale | −2,009 | $334.98 | $673K | 9,137 |
| 2021-01-11 | Hippel James Chief Financial Officer | Option exercise · Stock Options (Right to Buy) | −10,000 | 49,942 | ||
| 2020-12-07 | Kummeth Charles R. Chief Executive Officer | Sale | −5,000 | $308.00 | $1.5M | 166,269 |
| 2020-11-30 | Furlow Brenda S. SVP - General Counsel | Option exercise | +10,857 | $106.59 | $1.2M | 16,043 |
| 2020-11-30 | Furlow Brenda S. SVP - General Counsel | Option exercise | +938 | $106.59 | $100K | 16,981 |
| 2020-11-30 | Furlow Brenda S. SVP - General Counsel | Sale | −3,367 | $301.32 | $1.0M | 13,614 |
| 2020-11-30 | Furlow Brenda S. SVP - General Counsel | Sale | −6,783 | $302.15 | $2.0M | 6,831 |
| 2020-11-30 | Furlow Brenda S. SVP - General Counsel | Sale | −707 | $302.82 | $214K | 6,124 |
Page 36 of 53 · 1,043 trades